INFU:NYE-InfuSystems Holdings Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 8.8

Change

+0.29 (+3.41)%

Market Cap

USD 0.20B

Volume

0.04M

Analyst Target

USD 24.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 66.90B
ALC Alcon AG

N/A

USD 38.91B
HYB New America High Income Closed..

N/A

USD 35.93B
RMD ResMed Inc

N/A

USD 27.76B
WST West Pharmaceutical Services I..

N/A

USD 27.24B
BAX Baxter International Inc

N/A

USD 20.44B
TFX Teleflex Incorporated

N/A

USD 10.10B
ATR AptarGroup Inc

N/A

USD 9.48B
STVN Stevanato Group SpA

N/A

USD 7.29B
BLCO Bausch + Lomb Corp

N/A

USD 5.19B

ETFs Containing INFU

FTXR First Trust Nasdaq Transp.. 8.35 % 0.60 %

N/A

USD 0.04B
RDIV Invesco S&P Ultra Dividen.. 5.64 % 0.39 %

N/A

USD 0.74B
WBIY WBI Power Factor® High D.. 5.04 % 0.70 %

N/A

USD 0.06B
RPV Invesco S&P 500® Pure Va.. 2.83 % 0.35 %

N/A

USD 2.02B
VLUE 2.38 % 0.15 %

N/A

N/A
QDVI:F iShares IV Public Limited.. 2.31 % 0.00 %

N/A

USD 2.09B
QDVI:XETRA iShares Edge MSCI USA Val.. 2.31 % 0.00 %

N/A

USD 2.09B
ZVU:CA BMO MSCI USA Value ETF 2.29 % 0.33 %

N/A

CAD 0.12B
IUVD:LSE iShares Edge MSCI USA Val.. 2.27 % 0.00 %

N/A

USD 2.01B
IUVF:LSE iShares Edge MSCI USA Val.. 2.27 % 0.00 %

N/A

USD 2.01B
IUVL:LSE iShares Edge MSCI USA Val.. 2.27 % 0.00 %

N/A

USD 2.01B
DVYL 2.17 % 0.00 %

N/A

N/A
SPYD SPDR® Portfolio S&P 500 .. 1.47 % 0.08 %

N/A

USD 6.65B
RCD 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.51% 5% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.51% 5% F 7% C-
Trailing 12 Months  
Capital Gain 16.71% 74% C 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.71% 68% D+ 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.48% 80% B- 86% B+
Dividend Return 21.48% 80% B- 85% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.38% 25% F 13% F
Risk Adjusted Return 32.85% 70% C- 58% F
Market Capitalization 0.20B 21% F 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.